Objective: We validated the Chinese version of the Ureteral Stent Symptoms Questionnaire (USSQ) in patients with an indwelling ureteric stent. Patients and Methods: The English version of the USSQ was translated into Chinese using a multi-step process by 3 urologists and 2 independent translators. The Chinese version was validated by asking 50 patients with temporary unilateral ureteral stent to complete the questionnaire at weeks 1 and 4 after stent placement. Thirty healthy individuals without a ureteral stent were also asked to complete the Chinese USSQ once. The psychometric properties of the questionnaire were analyzed. Results: After revision of the initial 2 drafts after translation, back translation, and pilot testing, a final draft was developed that underwent field testing. Psychometric analyses revealed satisfactory internal consistencies and test-retest reliability for all domains except for sexual matters. Most USSQ domains showed moderate correlations with each other. It demonstrated satisfactory discriminant validity (sensitivity to change, p < 0.05) and test-retest reliability. Analysis of the domains of the sexual matters was limited because of the small proportion of the study population for whom it was applicable. Conclusion: The Chinese version of the USSQ is a reliable and valid instrument to evaluate symptoms and health-related quality of life in Chinese patients with ureteric stents.

Keywords:
Ureteral stent symptoms questionnaire, Chinese, Ureteral stent, Validation, Introduction
1.
Finney RP: Experience with new double J ureteral catheter stent. J Urol 1978; 120: 678–681.
2.
Chew BH, Knudsen BE, Denstedt JD: The use of stents in contemporary urology. Curr Opin Urol 2004; 14: 111–115.
3.
Chew BH, Seitz C: Impact of ureteral stenting in ureteroscopy. Curr Opin Urol 2016; 26: 76–80.
4.
El-Nahas AR, Elsaadany MM, Tharwat M, et al: Validation of the arabic linguistic version of the ureteral stent symptoms questionnaire. Arab J Urol 2014; 12: 290–293.
5.
Joshi HB, Stainthorpe A, Macdonagh RP, et al: Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003;169: 1065–1069.
6.
El-Nahas AR, El-Assmy AM, Shoma AM, et al: Self-retaining ureteral stents: analysis of factors responsible for patients’ discomfort. J Endourol 2006; 20: 33–37.
7.
Zhou L, Cai X, Li H, et al: Effects of α-Blockers, Antimuscarinics, or Combination Therapy in Relieving Ureteral Stent-Related Symptoms: A Meta-Analysis. Centre for Reviews and Dissemination (UK), 2015.
8.
Huang T, Wang LH, Gao XF, et al: Clinical observation of doxazosin combined with compound desmodium in the treatment of symptoms related to double J stents in female patients. Shandong Med 2010; 50: 58–59.
9.
Lange D, Bidnur S, Hoag N, et al: Ureteral stent-associated complications – where we are and where we are going. Nat Rev Urol 2015; 12: 17–25.
10.
Joshi HB, Newns N, Stainthorpe A, et al: Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003; 169: 1060–1064.
11.
Giannarini G, Jr FX K, Valent F, et al: The Italian linguistic validation of the ureteral stent symptoms questionnaire. J Urol 2008; 180: 624–628.
12.
Sanguedolce F, Millán-Rodriguez F, Santillana-Altimira JM, et al: The Spanish linguistic validation of the ureteral stent symptom questionnaire. J Endourol 2014; 28: 237–242.
13.
Puichaud A, Larré S, Bruyère F, et al: [The french linguistic validation of the ureteric stent symptom questionnaire (USSQ)]. Prog Urol 2010;20: 210–213.
14.
Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417–1432.
15.
Guyatt GH, Kirshner B, Jaeschke R: Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992; 45: 1341–1345.
16.
Cella DF, Tulsky DS: Measuring quality of life today: methodological aspects. Oncology (Willston Park) 1990; 4: 29–38.
17.
Park J, Shin DW, You C, et al: Cross-cultural application of the korean version of ureteral stent symptoms questionnaire. J Endourol 2012; 26: 1518–1522.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.